Cargando…
The Novel Bone Alkaline Phosphatase Isoform B1x Is Associated with Improved 5-Year Survival in Chronic Kidney Disease
Circulating alkaline phosphatase (ALP) is an independent cardiovascular risk marker. Serum bone ALP (BALP) isoforms indicate bone turnover and comprise approximately 50% of total circulating ALP. In chronic kidney disease (CKD), mortality is highest in patients with increased ALP and BALP and low bo...
Autores principales: | Haarhaus, Mathias, Fernström, Anders, Qureshi, Abdul Rashid, Magnusson, Per |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708752/ https://www.ncbi.nlm.nih.gov/pubmed/34959954 http://dx.doi.org/10.3390/nu13124402 |
Ejemplares similares
-
Pharmacologic epigenetic modulators of alkaline phosphatase in chronic kidney disease
por: Haarhaus, Mathias, et al.
Publicado: (2020) -
Alkaline Phosphatase: An Old Friend as Treatment Target for Cardiovascular and Mineral Bone Disorders in Chronic Kidney Disease
por: Haarhaus, Mathias, et al.
Publicado: (2022) -
Bone Alkaline Phosphatase and Tartrate-Resistant Acid Phosphatase: Potential Co-regulators of Bone Mineralization
por: Halling Linder, Cecilia, et al.
Publicado: (2017) -
Alkaline Phosphatase in Bone Tumours
por: Chitre, R. G.
Publicado: (1943) -
Sclerostin─A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene?
por: Jankowska, Magdalena, et al.
Publicado: (2017)